Postprandial Glucose: Marker or Risk Factor?

por Avogaro, Angelo
Publicado 2011

Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives

por Boscari, Federico, Avogaro, Angelo
Publicado 2021

It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications

por Fadini, Gian Paolo, Avogaro, Angelo
Publicado 2012

How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors

por Fadini, Gian Paolo, Avogaro, Angelo
Publicado 2018

Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection

por Avogaro, Angelo, de Kreutzenberg, Saula, Fadini, Gianpaolo
Publicado 2014

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System

por Fadini, Gian Paolo, Sarangdhar, Mayur, Avogaro, Angelo
Publicado 2018

Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions

por Fadini, Gian Paolo, Sarangdhar, Mayur, Avogaro, Angelo
Publicado 2018

Managing diabetes in diabetic patients with COVID: where do we start from?

por Avogaro, Angelo, Bonora, Benedetta, Fadini, Gian Paolo
Publicado 2021

Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence

por Bonora, Benedetta Maria, Avogaro, Angelo, Fadini, Gian Paolo
Publicado 2020

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients a...

por Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Publicado 2020

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice

por Morieri, Mario Luca, Avogaro, Angelo, Fadini, Gian Paolo
Publicado 2020

Response to Chia Siang Kow and colleagues

por Avogaro, Angelo, Bonora, Benedetta Maria, Fadini, Gian Paolo
Publicado 2022

Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience

por Lenzini, Livia, Carraro, Gianni, Avogaro, Angelo, Vitturi, Nicola
Publicado 2022

Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown

por Boscari, Federico, Ferretto, Sara, Uliana, Ambra, Avogaro, Angelo, Bruttomesso, Daniela
Publicado 2021

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

por Bonora, Benedetta Maria, Raschi, Emanuel, Avogaro, Angelo, Fadini, Gian Paolo
Publicado 2021

Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors

por Fadini, Gian Paolo, Del Prato, Stefano, Avogaro, Angelo, Solini, Anna
Publicado 2021

The Endothelium Abridges Insulin Resistance to Premature Aging

por Avogaro, Angelo, de Kreutzenberg, Saula Vigili, Federici, Massimo, Fadini, Gian Paolo
Publicado 2013

Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

por Morieri, Mario Luca, Lamacchia, Olga, Manzato, Enzo, Giaccari, Andrea, Avogaro, Angelo
Publicado 2022

Amelioration of Glucose Control Mobilizes Circulating Pericyte Progenitor Cells in Type 2 Diabetic Patients with Microangiopathy

por Fadini, Gian Paolo, Mancuso, Patrizia, Bertolini, Francesco, de Kreutzenberg, Saula, Avogaro, Angelo
Publicado 2012

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms

por Avogaro, Angelo, Albiero, Mattia, Menegazzo, Lisa, de Kreutzenberg, Saula, Fadini, Gian Paolo
Publicado 2011